It has been demonstrated that osteoclasts are mainly located in the synovial inflammatory tissue, and the bone destruction occurred in RA belongs to osteoclast-mediated bone destruction that is regulated by the receptor activator of nuclear factor-κB (RANK) ligand (RANKL) [4]. Here, TNFRSF11A is linked to rheumatoid arthritis.